Evidence map›Paper›PMID 24057772›Full record

ReviewCurrent cardiology reports2013

Medication adherence in patients with diabetes and dyslipidemia: associated factors and strategies for improvement.

Lucas N Marzec, Thomas M Maddox

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Association of Polypharmacy and Burden of Comorbidities on COVID-19 Adverse Outcomes in People with Type 1 or Type 2 Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Association of Social Support and Medication Adherence in Chinese Patients with Type 2 Diabetes Mellitus.International journal of environmental research and public health · 2017
    Article
  17. Article
  18. Patients' beliefs on the impediments to good diabetes control: a mixed methods study of patients in general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2016
    Article
  19. Article
  20. Patient-reported financial barriers to adherence to treatment in neurology.ClinicoEconomics and outcomes research : CEOR · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lucas N MarzecVA Eastern Colorado Health Care System, Cardiology Section, 111B, 1055 Clermont Street, Denver, CO, 80220, USA.
Thomas M Maddox
VA Eastern Colorado Health Care System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dyslipidemia and diabetes mellitus are commonly coincident, and together contribute to the development of atherosclerotic disease. Medication therapy is the mainstay of treatment for dyslipidemia. Optimal medication therapy for dyslipidemia in patients with diabetes reduces cardiovascular events but necessitates patients take multiple medications. As a result, sub-optimal adherence to medication therapy is common. Factors contributing to medication non-adherence in patients taking multiple medications are complex and can be grouped into patient-, social and economic-, medication therapy-, and health provider and health system-related factors. Strategies aimed at improving medication adherence may target the patient, health care providers, or health systems. Recent data suggest medication non-adherence contributes to racial health disparities. In addition, health literacy, cost-related medication non-adherence, and patient beliefs regarding medication therapy have all been recently described as factors affecting medication adherence. Data from within the last year support an important role for regular contact between patients and health care providers to effectively address these factors. Cost-related barriers to medication adherence have recently been addressed through examination of health system approaches to decreasing cost-related non-adherence.

Indexed as

Medication AdherenceAntihypertensive AgentsAtherosclerosisDiabetes Mellitus, Type 2Diabetic AngiopathiesDyslipidemiasHealth ExpendituresHealth Knowledge, Attitudes, PracticeHealth LiteracyHumansHypoglycemic AgentsHypolipidemic AgentsPatient Education as TopicPrevalenceRisk FactorsSocioeconomic FactorsAntihypertensive AgentsHypoglycemic AgentsHypolipidemic Agents

Identifiers

PMID24057772
OpenAlexW2010559564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.